etomoxir has been researched along with ubiquinone in 2 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (ubiquinone) | Trials (ubiquinone) | Recent Studies (post-2010) (ubiquinone) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 9,497 | 597 | 3,655 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, EJ; Davis, B; Murphy, MP; Neufer, PD; Robidoux, J; Rogers, C | 1 |
| He, W; Li, J; Liao, B; Yang, J | 1 |
2 other study(ies) available for etomoxir and ubiquinone
| Article | Year |
|---|---|
A transient increase in lipid peroxidation primes preadipocytes for delayed mitochondrial inner membrane permeabilization and ATP depletion during prolonged exposure to fatty acids.
Topics: Adenosine Triphosphate; Adipocytes; Carnosine; Cell Death; Cell Differentiation; Cell Line, Transformed; Cyclosporine; Epoxy Compounds; Fatty Acids; Gene Expression; Humans; Lipid Peroxidation; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membranes; Organophosphorus Compounds; Oxidative Stress; Permeability; Piperidines; Reactive Oxygen Species; Superoxides; Ubiquinone | 2014 |
FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus.
Topics: Adult; Animals; Apoptosis; Benzothiazoles; Bone Density; Cross-Sectional Studies; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Epoxy Compounds; Fatty Acids, Nonesterified; Humans; Lipid Peroxidation; Male; Mice, Inbred C57BL; Middle Aged; Mitochondria; Organophosphorus Compounds; Osteoblasts; Osteogenesis; Reactive Oxygen Species; Toluene; Tumor Suppressor Protein p53; Ubiquinone | 2015 |